Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial.

Benigno Rodriguez, David M. Asmuth, Roy M. Matining, John Spritzler, Jeffrey M. Jacobson, Robbie B. Mailliard, Xiao Dong Li, Ana I. Martinez, Allan R. Tenorio, Franco Lori, Julianna Lisziewicz, Suria Yesmin, Charles R. Rinaldo, Richard B. Pollard

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Fingerprint Dive into the research topics of 'Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial.'. Together they form a unique fingerprint.

Medicine & Life Sciences